Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
3.080
+0.790 (34.50%)
At close: Aug 13, 2025, 4:00 PM
2.950
-0.130 (-4.22%)
Pre-market: Aug 14, 2025, 9:08 AM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $276.95 million as of August 14, 2025. Its market cap has decreased by -37.64% in one year.
Market Cap
276.95M
Enterprise Value
119.59M
1-Year Change
-37.64%
Ranking
Category
Stock Price
$3.08
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $276.95M, a decrease of -57.37%. That is a compound annual growth rate of -8.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 277.00M | 164.31% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |